Dynamics of major histocompatibility complex class II-positive cells in the postischemic brain--influence of levodopa treatment.
about
Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental strokeClinical Trials of Immunomodulation in Ischemic Stroke.MicroRNA-124-loaded nanoparticles increase survival and neuronal differentiation of neural stem cells in vitro but do not contribute to stroke outcome in vivo.The role of dopaminergic immune cell signalling in poststroke inflammation.Targeted intracerebral delivery of the anti-inflammatory cytokine IL13 promotes alternative activation of both microglia and macrophages after stroke.The Intersection of Central Dopamine System and Stroke: Potential Avenues Aiming at Enhancement of Motor Recovery
P2860
Dynamics of major histocompatibility complex class II-positive cells in the postischemic brain--influence of levodopa treatment.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Dynamics of major histocompati ...... fluence of levodopa treatment.
@ast
Dynamics of major histocompati ...... fluence of levodopa treatment.
@en
type
label
Dynamics of major histocompati ...... fluence of levodopa treatment.
@ast
Dynamics of major histocompati ...... fluence of levodopa treatment.
@en
prefLabel
Dynamics of major histocompati ...... fluence of levodopa treatment.
@ast
Dynamics of major histocompati ...... fluence of levodopa treatment.
@en
P2860
P1476
Dynamics of major histocompati ...... fluence of levodopa treatment.
@en
P2093
Enida Kuric
Karsten Ruscher
P2860
P2888
P356
10.1186/S12974-014-0145-Z
P577
2014-08-23T00:00:00Z
P5875
P6179
1001747786